勒梅特血管
LMAT
80.82
-2.34
-2.81%
勒梅特血管
US · LMAT
#2839 按市值排名
上市于 1970
80.82
-2.34
-2.81%
实时 - 追踪5344个代码 - 心跳于510秒前
· 2026-10-16 19:30
✦ 量化财务健康度 计算方式说明
良好
- 奥特曼 Z 值为7.02，高于3.0的"安全区"阈值。
- 该模型对工业和制造业公司最为可靠，对银行、保险等金融类公司参考意义较弱。
营收 年度数据，近8年
最近年度同比+13.53%
利润率
- 毛利率
- 71.53%
- 营业利润率
- 27.21%
- 净利率
- 23.13%
关键比率与质量指标
PEG 计算采用滚动市盈率与过去3年净利润增长率（40.91%/年）的比值，由于此处没有前瞻盈利预测数据，因此这并非"前瞻PEG"。 奥特曼 Z 值低于约1.8提示财务困境风险，高于约3.0提示风险较低；该模型对工业和制造业公司最为可靠，对银行等金融类公司参考意义较弱。
利润表
| 项目 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 营收 | 105.57M | 117.23M | 129.37M | 154.42M | 161.65M | 193.48M | 219.86M | 249.60M |
| 毛利润 | 73.94M | 79.85M | 84.62M | 101.38M | 104.90M | 127.05M | 150.90M | 178.54M |
| 销售及管理费用 | 45.01M | 49.39M | 46.20M | 53.16M | 61.67M | 72.89M | 83.00M | 96.49M |
| 研发费用 | 8.20M | 9.28M | 10.10M | 11.80M | 13.29M | 16.97M | 15.65M | 14.14M |
| 营业利润 | 20.74M | 21.18M | 28.32M | 36.43M | 29.94M | 37.20M | 52.26M | 67.91M |
| 税前利润 | 28.44M | 21.68M | 27.36M | 34.29M | 27.49M | 39.48M | 56.88M | 75.18M |
| 税费 | 5.50M | 3.75M | 6.14M | 7.38M | 6.85M | 9.37M | 12.84M | 17.45M |
| 净利润 | 22.94M | 17.93M | 21.22M | 26.91M | 20.64M | 30.11M | 44.04M | 57.73M |
| 基本每股收益 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 |
| 稀释每股收益 | 1.13 | 0.88 | 1.04 | 1.25 | 0.93 | 1.34 | 1.93 | 2.52 |
| 项目 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| 营收 | 59.87M | 64.23M | 61.05M | 64.45M | 66.55M | 70.38M |
| 毛利润 | 41.42M | 44.97M | 45.96M | 46.19M | 48.40M | 50.76M |
| 销售及管理费用 | 24.70M | 25.29M | 22.67M | 23.83M | 26.56M | 25.52M |
| 研发费用 | 4.10M | 3.54M | 2.97M | 3.53M | 4.06M | 4.85M |
| 营业利润 | 12.63M | 16.14M | 20.31M | 18.83M | 17.78M | 20.40M |
| 税前利润 | 14.24M | 18.07M | 22.57M | 20.30M | 19.67M | 22.19M |
| 税费 | 3.23M | 4.29M | 5.21M | 4.72M | 3.99M | 5.14M |
| 净利润 | 11.01M | 13.78M | 17.36M | 15.58M | 15.68M | 17.05M |
| 基本每股收益 | 0 | 1 | 1 | 1 | 1 | 1 |
| 稀释每股收益 | 0.48 | 0.60 | 0.75 | 0.68 | 0.68 | 0.74 |
资产负债表
| 项目 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 流动资产总额 | 94.02M | 92.09M | 94.26M | 139.88M | 161.73M | 194.60M | 402.19M | 468.23M |
| 现金及短期投资 | 47.99M | 32.68M | 26.98M | 69.96M | 82.69M | 105.07M | 299.72M | 359.12M |
| 存货 | 25.57M | 34.63M | 39.17M | 40.65M | 45.28M | 52.33M | 55.94M | 58.25M |
| 总资产 | 153.09M | 188.34M | 252.81M | 292.80M | 310.48M | 346.78M | 551.82M | 615.69M |
| 流动负债总额 | 19.76M | 20.85M | 25.15M | 21.81M | 25.33M | 29.88M | 30.61M | 36.32M |
| 短期负债 | -- | 1.76M | 4.45M | 1.87M | 1.89M | 2.47M | 2.68M | 2.94M |
| 长期负债 | -- | -- | 35.53M | -- | -- | -- | 167.77M | 168.65M |
| 总负债 | 22,853,000.00 | 40,200,000.00 | 80,238,000.00 | 38,651,000.00 | 42,275,000.00 | 48,878,000.00 | 214,527,000.00 | 222,174,000.00 |
| 股东权益总额 | 130.24M | 148.14M | 172.57M | 254.15M | 268.20M | 297.90M | 337.29M | 393.52M |
| 留存收益 | 45.83M | 57.03M | 70.55M | 88.13M | 97.77M | 115.43M | 145.09M | 184.72M |
| 项目 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| 流动资产总额 | 408.11M | 430.13M | 452.03M | 468.23M | 477.82M | 488.30M |
| 现金及短期投资 | 302.55M | 319.49M | 343.06M | 359.12M | 367.23M | 376.24M |
| 存货 | 55.97M | 57.46M | 58.93M | 58.25M | 57.77M | 57.94M |
| 总资产 | 556.01M | 577.59M | 598.07M | 615.69M | 629.53M | 640.55M |
| 流动负债总额 | 24.75M | 30.82M | 33.29M | 36.32M | 33.37M | 29.94M |
| 短期负债 | 2.64M | 2.83M | 2.79M | 2.94M | 3.45M | 3.44M |
| 长期负债 | 167.98M | 168.21M | 168.42M | 168.65M | 168.87M | 169.09M |
| 总负债 | 208,434,000.00 | 214,905,000.00 | 219,146,000.00 | 222,174,000.00 | 222,904,000.00 | 220,207,000.00 |
| 股东权益总额 | 347.57M | 362.69M | 378.92M | 393.52M | 406.62M | 420.34M |
| 留存收益 | 151.58M | 160.84M | 173.67M | 184.72M | 194.68M | 206.02M |
现金流量表
| 项目 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 经营活动现金流 | 19.51M | 14.18M | 34.80M | 35.10M | 25.38M | 36.75M | 44.12M | 81.25M |
| 折旧与摊销 | 4.32M | 5.42M | 8.40M | 11.07M | 9.43M | 9.52M | 9.61M | 10.42M |
| 自由现金流 | 16.45M | 10.42M | 31.82M | 30.22M | 22.15M | 29.49M | 37.16M | 74.47M |
| 已派股息 | -5.45M | -6.74M | -7.70M | -9.34M | -10.99M | -12.45M | -14.38M | -18.11M |
| 股票回购/发行 | 2.23M | 4.17M | 5.40M | 63.24M | 3.47M | -- | -- | -- |
| 期末现金余额 | 26.32M | 11.79M | 26.76M | 13.86M | 19.13M | 24.27M | 25.61M | 28.24M |
| 项目 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| 经营活动现金流 | 9.04M | 20.29M | 28.76M | 23.16M | 15.09M | 15.97M |
| 折旧与摊销 | 2.55M | 2.65M | 2.61M | 2.61M | 2.62M | 2.66M |
| 自由现金流 | 7.66M | 18.95M | 26.48M | 21.38M | 12.31M | 13.65M |
| 已派股息 | -4.52M | -4.52M | -4.54M | -4.54M | -5.71M | -5.72M |
| 股票回购/发行 | -- | -- | -- | -- | -- | -- |
| 期末现金余额 | 25.34M | 27.18M | 25.49M | 28.24M | 26.85M | 26.63M |
回报与效率指标
| 项目 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 净资产收益率i | 19.12 | 12.88 | 13.23 | 12.61 | 7.90 | 10.64 | 13.87 | 15.80 |
| 总资产收益率i | 16.42 | 10.51 | 9.62 | 9.86 | 6.84 | 9.16 | 9.80 | 9.89 |
| 投入资本回报率i | 18.70 | 11.21 | 11.29 | 11.46 | 7.17 | 9.22 | 9.61 | 11.20 |
| 5年平均净资产收益率i | 13.25 | 14.57 | 15.09 | 15.05 | 13.15 | 11.45 | 11.65 | 12.16 |
| 息税前利润率i | 26.95 | 18.49 | 22.16 | 23.64 | 17.01 | 20.40 | 25.96 | 32.20 |
| 自由现金流/营收i | 15.58 | 8.89 | 24.60 | 19.57 | 13.70 | 15.24 | 16.90 | 29.83 |
| 流动比率i | 4.76 | 4.42 | 3.75 | 6.41 | 6.39 | 6.51 | 13.14 | 12.89 |
| 速动比率i | 3.22 | 2.36 | 1.85 | 4.11 | 4.13 | 4.36 | 10.77 | 10.81 |
| 资产负债率i | 0.00 | 8.34 | 21.67 | 5.44 | 5.35 | 5.51 | 33.65 | 30.14 |
| 长期负债权益比i | -- | 9.42 | 29.16 | 5.53 | 5.48 | 5.58 | 54.26 | 46.41 |
| 利息保障倍数i | 14,223.00 | -- | 21.88 | 16.45 | -- | -- | 278.44 | 15.50 |
| 营收复合年增长率(3年)i | 10.45 | 9.56 | 8.65 | 13.52 | 11.30 | 14.36 | 12.50 | 15.58 |
| 净利润复合年增长率(3年)i | 43.54 | 19.20 | 7.30 | 5.46 | 4.79 | 12.37 | 17.85 | 40.91 |
| 自由现金流复合年增长率(3年)i | 21.61 | -9.50 | 24.59 | 22.47 | 28.58 | -2.51 | 7.14 | 49.81 |
| 项目 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| 净资产收益率i | 13.77 | 13.81 | 15.02 | 15.80 | 16.55 | 16.77 |
| 总资产收益率i | 9.93 | 10.02 | 10.94 | 9.89 | 10.53 | 10.78 |
| 投入资本回报率i | 9.53 | 9.60 | 10.44 | 11.20 | 11.76 | 12.03 |
| 5年平均净资产收益率i | -- | -- | -- | -- | -- | -- |
| 息税前利润率i | 26.44 | 27.14 | 30.31 | 32.20 | 33.48 | 34.27 |
| 自由现金流/营收i | 18.17 | 22.30 | 27.50 | 29.83 | 30.87 | 28.13 |
| 流动比率i | 16.49 | 13.96 | 13.58 | 12.89 | 14.32 | 16.31 |
| 速动比率i | 13.65 | 11.55 | 11.28 | 10.81 | 12.08 | 13.76 |
| 资产负债率i | 33.34 | 32.18 | 31.04 | 30.14 | 30.15 | 29.70 |
| 长期负债权益比i | 52.57 | 50.47 | 48.25 | 46.41 | 45.83 | 44.44 |
| 利息保障倍数i | 40.01 | 22.79 | 17.84 | 15.50 | 16.52 | 17.30 |
| 营收复合年增长率(3年)i | -- | -- | -- | -- | -- | -- |
| 净利润复合年增长率(3年)i | -- | -- | -- | -- | -- | -- |
| 自由现金流复合年增长率(3年)i | -- | -- | -- | -- | -- | -- |
营收构成 最近报告期
业务分部
Development, manufacturing, and marketing of medical devices and implants, as well as the processing100.00%
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
勒梅特血管 讨论区 0 条评论